Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bactericidal activity of octophene].

M G Bellotti, A Raimondi, R Mattina

    Giornale Di Batteriologia, Virologia Ed Immunologia
    |July 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysis.

    ESMO open·2026
    Same author

    Early- and advanced-stage MSI-H non-colorectal cancers: best management and challenges in 2025.

    ESMO gastrointestinal oncology·2026
    Same author

    Toxicological risk profiles in suicide: The forensic value of hair-based substance detection.

    Legal medicine (Tokyo, Japan)·2026
    Same author

    Cetuximab rechallenge in molecularly selected metastatic colorectal cancer: the randomized CAVE-2 GOIM trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2025
    Same author

    Impact of age and sex on the efficacy and safety of ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy: a subgroup analysis of the ARMANI phase III trial.

    ESMO open·2025
    Same author

    Focal acute cholecystitis misdiagnosed as gallbladder carcinoma.

    Journal of ultrasound·2025

    Clofoctol demonstrates potent bactericidal activity against common gram-positive bacteria like Staphylococcus aureus and Streptococcus pyogenes. Its minimum bactericidal concentration (MBC) is low, confirming its primary role as a bactericidal agent.

    Area of Science:

    • Microbiology
    • Pharmacology
    • Infectious Diseases

    Background:

    • Gram-positive bacteria pose significant clinical challenges.
    • Understanding antimicrobial activity is crucial for effective treatment.

    Purpose of the Study:

    • To evaluate the in vitro bactericidal activity of Clofoctol.
    • To determine the minimum bactericidal concentration (MBC) against clinically isolated gram-positive microorganisms.

    Main Methods:

    • In vitro susceptibility testing.
    • Determination of minimum inhibitory concentration (MIC) and MBC.
    • Testing against clinical isolates of Staphylococcus aureus and Streptococcus pyogenes.

    Main Results:

    • Clofoctol exhibited potent bactericidal activity against Staphylococcus aureus and Streptococcus pyogenes.

    Related Experiment Videos

  • Minimum bactericidal concentrations (MBC) ranged from 1-8 mcg/ml for S. aureus and 2-8 mcg/ml for S. pyogenes.
  • Bactericidal activity against S. aureus was confirmed at MBC after 30 minutes.

    • Conclusions:

    • Clofoctol's primary antimicrobial activity is bactericidal.
    • The drug shows promising efficacy against key gram-positive pathogens.
    • Clofoctol's low MBC suggests potential for clinical application in treating gram-positive infections.